HPV: Is It in Your DNA

Monday, September 30, 2024

8:00 AM – 9:00 AM EDT

Location: MBCC, 207

CME/MOC Credit: 1

Disclosure(s):

Marianne Abouyared, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Rusha J. Patel, MD, FACS:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Antoine Eskander, MD, Sc.M., CIP, FRCSC:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

PROGRAM DESCRIPTION: The association of HPV with oropharyngeal cancers is now common knowledge. As a sexually transmitted infection, HPV-associated tumors naturally result in interesting and difficult patient-provider conversations. We will address helpful ways to approach these discussions, as well as address common dilemmas and questions regarding HPV vaccination. Additionally, there is emerging evidence that circulating HPV DNA (HPV ctDNA) can be identified with a simple blood test and an extremely useful adjunctive surveillance test. We will present the evidence in using ctDNA as a surveillance measure, how to incorporate this into your surveillance schedule, and also to discuss interesting and clinically relevant cases in which HPV ctDNA results are available. Through this case-based panel discussion, providers will be armed with all they need to approach HPV-associated oropharyngeal tumors with the most up-to-date and relevant medical knowledge.

Learning Objectives:

Interpret the evidence on HPV testing at diagnosis and in follow up for neck masses, unknown primary cancers, and non-oropharyngeal head and neck cancers including the use of circulating tumor DNA testing.
Demonstrate clinician communication with patients (and families) regarding the diagnosis of an HPV-associated malignancy
Recognize the effectiveness of HPV-vaccination and review impact of vaccination on sexual behavior in teens.

Moderator(s)

MA

Marianne Abouyared, MD

Assistant Professor
University of California Davis Medical Center
Sacramento, California, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Panelist(s)

ER

Eleni Rettig, MD, FACS

Brigham and Women's Hospital & Dana-Farber Cancer Institute, United States

Disclosure information not submitted.
RP

Rusha J. Patel, MD

Associate Professor
The University of Oklahoma Health Sciences Center, Department of Otolaryngology - Head and Neck Surgery
Oklahoma City, Oklahoma, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Antoine Eskander, MD, Sc.M., CIP, FRCSC

Associate Professor
Sunnybrook Health Sciences Centre and Michael Garron Hospital
Toronto, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.